Cartesian Therapeutics, Inc. Current Assets
Cartesian Therapeutics, Inc. (RNAC) had Current Assets of $153.62 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $153.62M.
- 2026-03-31: Assets, Current $122.04M.
- 2025-12-31: Assets, Current $129.28M.
- 2025-09-30: Assets, Current $147.26M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $153.62M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $122.04M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $129.28M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $147.26M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $163.40M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $185.12M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $216.63M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $229.14M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $124.78M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $111.11M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $90.73M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $89.87M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $122.72M 10-Q · filed 2023-08-17 | |
| 2023-03-31 | $138.39M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $148.14M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $159.68M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $172.57M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $130.01M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $144.44M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $151.77M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $166.81M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $163.13M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $151.34M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $166.50M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $61.05M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $74.44M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $96.67M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $36.12M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $44.45M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $59.53M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $42.08M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $55.57M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $68.83M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $84.98M 10-Q · filed 2018-05-09 | |
| 2018-01-01 | $98.68M 10-K · filed 2019-03-15 | $98.91M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $98.68M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $107.35M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $114.58M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $71.49M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $86.82M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $83.40M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $89.05M 10-Q · filed 2016-08-09 | |
| 2015-12-31 | $38.91M 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |